Tag: Impax Laboratories
Sanofi Seeking Billions from Mylan in EpiPen Antitrust Suit
Sordid details of anticompetitive behavior alleged in court filing.
Watch: As the EpiPen Shortage Drags On, Chicago Mom Spells Out...
"This Is Literally The Difference Between Life And Death For My Kid."
EpiPen? Generic? Impax? Auto-Injector? Sorting Through the Lingo with Videos and...
It's true... the lingo can be confusing, so let's sort through the names so we're all on the same page.
Pfizer’s Woes Go Beyond Affecting The Availability of Your Auto-Injectors
Vital drugs are in short supply at hospitals across the country forcing medical staff to substitute with less effective drugs.
The Epinephrine Auto-Injector Shortage and the Roaring Silence
Hear that roar from the institutions tasked with keeping us safe and informed? No, we don't either.
In Honor of Food Allergy Awareness Week, Epic Failures by Our...
During this week of awareness, let's turn up the heat on the very institutions charged with keeping our families safe.
FDA Officially Declares Shortage of EpiPen, Adrenaclick Generic; Auvi-Q Readily Available
This article contains information from the FDA website regarding the shortages.
Marketer of Generic Epinephrine Auto-Injector to be Acquired
Impax Laboratories is being acquired to form the fifth largest generics business in the US.
Auvi-Q Takes Center Stage at School Nurse Conference
One example of the changing market dynamics for epinephrine auto-injectors in light of recent developments.
Welcome Symjepi™: Adamis’ Prefilled Epinephrine Syringe Receives FDA Approval
The additional competition should help lower costs across the emergency epinephrine market.
